Abstracts tagged "Sjogren’s syndrome and interleukins (IL)"

Abstract Number: 2793 • 2015 ACR/ARHP Annual Meeting
IL35 Serum Level Is Decreased in Patients with Primary Sjogren Syndrome, Essentially in Patients with the More Active Disease Data from the French Prospective Assess Cohort
Olivier Fogel¹, Raphaèle Seror², Gaetane Nocturne³, Elodie Rivière⁴, Saida Boudaoud⁵, Jacques Gottenberg⁶, Véronique Le Guern⁷, Xavier Mariette⁸, Jean-Jacques Dubost⁹ and Corinne Miceli-Richard¹⁰, ¹INSERM U1012, Paris Sud University, Le Kremlin Bicêtre, France, ²Rheumatology, AP-HP Bicêtre Hospital / Paris-Sud University, Le Kremlin-Bicêtre, France, ³INSERM U1012, Université Paris Sud, Le Kremlin Bicêtre, France, ⁴Unité INSERM 1184 Université Paris Sud, le Kremlin Bicetre, France, ⁵INSERM U1012 - Université Paris XI, Le Kremlin Bicêtre, France, ⁶Hautepierre, Strasbourg, France, ⁷National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁸Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France, ⁹Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, ¹⁰Rheumatology, Hôpitaux Paris Sud & INSERM U1184, Le Kremlin Bicêtre, France
Background/Purpose: Primary Sjögren’s Syndrome (pSS) is an autoimmune disease mediated by B-cells as evidenced by the occurrence of non-Hodgkin lymphoma and increased B-cell markers in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].